https://www.selleckchem.com/pr....oducts/CHR-2797(Tose
In multivariate analyses, high baseline low-density lipoprotein levels were associated with worse survival (P = 0.046). Atorvastatin was not shown to improve PFS-6. However, this study identified that high low-density lipoprotein levels are an independent predictor of poor cancer-related outcomes. Future clinical trials testing statins should aim to enroll patients with slow-growing tumors.Clinical trial information NCT0202957 (December 12, 2013).Tedizolid is a new oxazolidinone antibiotic with little real-life data on use
Me gusta
Comentario
Compartir
